As shown, the proliferation (Figs. 5E, S1C) as well as migration (Figs. 5F, S1D) were inhibited by treatment with MK2206 in KCNAB2-KO NSCLC cells. Here, KCNAB2 is linked to non-small cell lung carcinoma.